This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bayer Pharma Aktiengesellschaft. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Jan Nedrikat: Innovator in Oral Contraception
Introduction
Jan Nedrikat is a notable inventor based in Kirkland, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral contraceptives. His innovative approach has led to the creation of a unique combination preparation that addresses both contraception and dysfunctional uterine bleeding.
Latest Patents
Jan Nedrikat holds a patent for a combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding. This patent, titled "Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same," outlines a multiphase combination preparation. The preparation consists of various dosage units containing specific amounts of estradiol valerate and dienogest, designed to provide effective treatment for women.
Career Highlights
Jan is currently associated with Bayer Pharma Aktiengesellschaft, where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key player in the field of women's health.
Collaborations
Throughout his career, Jan has collaborated with talented professionals such as Susan Zeun and Pol Boudes. These partnerships have fostered a creative environment that encourages the development of groundbreaking solutions in healthcare.
Conclusion
Jan Nedrikat's contributions to the field of oral contraception and women's health are commendable. His innovative patent and collaborative efforts highlight his commitment to improving healthcare solutions.